Overview

Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU

Status:
Not yet recruiting
Trial end date:
2020-12-15
Target enrollment:
0
Participant gender:
All
Summary
The current study aimed to determine the incidence of hypophosphatemia (HP) among severe sepsis/septic shock patients admitted to ICU and its impact on morbidity and mortality rates of these patients, and to evaluate the impact of phosphorous supplemental therapy (PST) on such outcomes.Thus, this study will hypothesize that diagnosis and management of HP may be advantageous for reduction of morbidity and mortality rates of septic patients admitted to ICU.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Treatments:
Anti-Bacterial Agents
Criteria
Inclusion Criteria:

- patients with severe sepsis and/or septic shock within 24 hours of admission to ICU

Exclusion Criteria:

- children and adulthoods younger than 18 years

- pregnancy

- severe hemorrhagic shock

- maintenance on immunosuppressant therapy for any indication

- patients who are expected to die within the first 24 hours after admission